| Title |
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
|
|---|---|
| Published in |
JACC, December 2012
|
| DOI | 10.1016/j.jacc.2012.10.027 |
| Pubmed ID | |
| Authors |
Stefan M. Nidorf, John W. Eikelboom, Charley A. Budgeon, Peter L. Thompson |
| Abstract |
The objective of this study was to determine whether colchicine 0.5 mg/day can reduce the risk of cardiovascular events in patients with clinically stable coronary disease. |
X Demographics
The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 9 | 25% |
| Japan | 4 | 11% |
| Iran, Islamic Republic of | 1 | 3% |
| United Kingdom | 1 | 3% |
| Kazakhstan | 1 | 3% |
| Mexico | 1 | 3% |
| France | 1 | 3% |
| Israel | 1 | 3% |
| Australia | 1 | 3% |
| Other | 5 | 14% |
| Unknown | 11 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 61% |
| Scientists | 8 | 22% |
| Practitioners (doctors, other healthcare professionals) | 5 | 14% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 594 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | <1% |
| Japan | 2 | <1% |
| Netherlands | 1 | <1% |
| Brazil | 1 | <1% |
| Iran, Islamic Republic of | 1 | <1% |
| Colombia | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 582 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 75 | 13% |
| Student > Ph. D. Student | 72 | 12% |
| Student > Bachelor | 59 | 10% |
| Student > Master | 53 | 9% |
| Other | 44 | 7% |
| Other | 131 | 22% |
| Unknown | 160 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 264 | 44% |
| Biochemistry, Genetics and Molecular Biology | 29 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 27 | 5% |
| Agricultural and Biological Sciences | 19 | 3% |
| Nursing and Health Professions | 15 | 3% |
| Other | 52 | 9% |
| Unknown | 188 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 111. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2024.
All research outputs
#388,218
of 25,832,559 outputs
Outputs from JACC
#915
of 16,962 outputs
Outputs of similar age
#2,600
of 290,747 outputs
Outputs of similar age from JACC
#3
of 149 outputs
Altmetric has tracked 25,832,559 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,962 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,747 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 149 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.